Latest Breaking News On - Healthcare investment banking at lincoln international - Page 1 : vimarsana.com

/PRNewswire/ COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles (CNPs) to treat immune disorders, today announced.

United statesJohn puisisBrianc bockPrior to lincoln internationalHealthcare investment banking at lincoln internationalNorthern arizona universityExicure incChief financial officerManaging directorHealthcare investment bankingLincoln internationalNorthern arizonaCour pharmaceutical development company inc